Seres Therapeutics is the top competitor of Second Genome. Seres Therapeutics is a Public company that was founded in Cambridge, Massachusetts in 2010. Like Second Genome, Seres Therapeutics also operates in the Biotechnology sector. Seres Therapeutics has 273 more employees vs. Second Genome.
Rebiotix is seen as one of Second Genome's biggest rivals. Rebiotix was founded in Roseville, Minnesota} in 2011. Like Second Genome, Rebiotix also competes in the Biotechnology space. Compared to Second Genome, Rebiotix generates $9.1M less revenue.